Dr. Chandramouli Chakinala M.D.

Recommended Articles

• University Dance Promotes Cystic Fibrosis Awareness

  Cystic fibrosis is considered incurable, and is a daily struggle for all of those who have it. Constant research is being poured into finding better treatment, and potentially even a cure, but Rowan's Public Relations Student Society of America (PRSSA) is putting their own spin (literally) on...

• 8 Doctor-Recommended Treatments for Bronchitis

  Bronchitis is inflammation of the cells lining the bronchial tubes. It is a lower respiratory tract infection that usually follows an upper respiratory tract infection from the Influenza virus or other infectious agent. Acute bronchitis can occur in anyone and is generally suspected when a person...

• When Could Orthopnea Mean Something More Serious?

  IntroductionOrthopnea is the medical term used when referring to the occurrence of dyspnea (shortness of breath) when you are lying flat. This symptom is often a sign of heart failure. However, orthopnea can also be due to other health conditions. Dyspnea (shortness of breath) is not the same with...

• All About Bronchopneumonia

  Pneumonia is an infection of the lung tissue, which can be caused by bacteria, viruses, and fungi. There are two types of pneumonia: lobar pneumonia and bronchopneumonia. Lobar pneumonia is when an entire lobe or more than one lobe of the lung gets involved. Bronchopneumonia happens when the bronchi...

• 5 Tips on Living with Pleurisy

  What is pleurisy?Pleurisy, also called as pleuritis, is the inflammation of the pleural membranes lining your lungs. These double-membraned pleura are important because they protect and lubricate your lungs as you breathe in and out. The small amount of fluid in the pleural cavity helps the two...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...